The Philippine Health Insurance Corporation (PhilHealth) on Friday pushed for early detection of breast cancer with its Z benefit package expansion, in line with Breast Cancer Awareness Month. Under ...

Georgia health insurers now cover biomarker testing, a crucial diagnostic tool in areas like cancer and Alzheimer's.

The company is using a recently closed funding round to drive commercialization of the test, which measures three proteins in urine to detect pancreatic cancer.

The San Diego-based biotech has been evaluating the oral NLRP3 inhibitor, dubbed VTX3232, in a phase 2 study of 175 patients ...

Researchers have identified new blood and spinal fluid biomarkers that could help track ALS progression and monitor treatment ...

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

In a finding set to change the way disease is monitored, Chandra Mohan, an international expert and pioneer in lupus research ...

Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...

Reduced kidney function from chronic kidney disease may undermine the accuracy of blood-based biomarkers used to predict AD outcomes.

But a new generation of noninvasive tests are emerging that could help accelerate diagnosis and improve management of this ...

A new blood test that could help doctors identify whether a patient has Alzheimer’s disease was cleared by the FDA last week.

On Tuesday, October 7, dozens of local healthcare providers gathered with the American Lung Association in South Carolina to discuss the latest advancements in lung cancer identification and treatment ...